Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Immune Checkpoint Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Immune Checkpoint Inhibitorsmarket, defines the market attractiveness level of Immune Checkpoint Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Immune Checkpoint Inhibitors industry, describes the types of Immune Checkpoint Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immune Checkpoint Inhibitors market and the development prospects and opportunities of Immune Checkpoint Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immune Checkpoint Inhibitors market in Chapter 13.
By Player:
Merck & Co
ArGEN-X
Seattle Genetics
NewLink Genetics
Roche / Genentech
Pfizer
Bristol Myer Squibb
CureTech
Immutep
AstraZeneca
Innate Pharma
Sorrento Therapeutics
MacroGenics
Incyte Corporation
GITR, Inc
Celldex Therapeutics
GlaxoSmithKline
By Type:
PD-1/PD-L1
CTLA-4
By End-User:
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Melanoma
Blood Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Immune Checkpoint Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Immune Checkpoint Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Immune Checkpoint Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Immune Checkpoint Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Immune Checkpoint Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Immune Checkpoint Inhibitors Consumption (2017-2022)
-
7.2 United States Immune Checkpoint Inhibitors Consumption (2017-2022)
-
7.3 Europe Immune Checkpoint Inhibitors Consumption (2017-2022)
-
7.4 China Immune Checkpoint Inhibitors Consumption (2017-2022)
-
7.5 Japan Immune Checkpoint Inhibitors Consumption (2017-2022)
-
7.6 India Immune Checkpoint Inhibitors Consumption (2017-2022)
-
7.7 South Korea Immune Checkpoint Inhibitors Consumption (2017-2022)
8 Region and Country-wise Immune Checkpoint Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Immune Checkpoint Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Immune Checkpoint Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Immune Checkpoint Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Immune Checkpoint Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Immune Checkpoint Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Immune Checkpoint Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Immune Checkpoint Inhibitors Consumption Forecast (2022-2028)
9 Global Immune Checkpoint Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Immune Checkpoint Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PD-1/PD-L1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CTLA-4 Consumption and Growth Rate (2017-2022)
-
9.2 Global Immune Checkpoint Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Other Consumption and Growth Rate (2017-2022)
10 Global Immune Checkpoint Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global PD-1/PD-L1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CTLA-4 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Immune Checkpoint Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Immune Checkpoint Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Immune Checkpoint Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Immune Checkpoint Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Immune Checkpoint Inhibitors Market Competitive Analysis
-
14.1 Merck & Co
-
14.1.1 Merck & Co Company Details
-
14.1.2 Merck & Co Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Immune Checkpoint Inhibitors Product and Service
-
14.2 ArGEN-X
-
14.2.1 ArGEN-X Company Details
-
14.2.2 ArGEN-X Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 ArGEN-X Immune Checkpoint Inhibitors Product and Service
-
14.3 Seattle Genetics
-
14.3.1 Seattle Genetics Company Details
-
14.3.2 Seattle Genetics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Seattle Genetics Immune Checkpoint Inhibitors Product and Service
-
14.4 NewLink Genetics
-
14.4.1 NewLink Genetics Company Details
-
14.4.2 NewLink Genetics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 NewLink Genetics Immune Checkpoint Inhibitors Product and Service
-
14.5 Roche / Genentech
-
14.5.1 Roche / Genentech Company Details
-
14.5.2 Roche / Genentech Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche / Genentech Immune Checkpoint Inhibitors Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Immune Checkpoint Inhibitors Product and Service
-
14.7 Bristol Myer Squibb
-
14.7.1 Bristol Myer Squibb Company Details
-
14.7.2 Bristol Myer Squibb Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol Myer Squibb Immune Checkpoint Inhibitors Product and Service
-
14.8 CureTech
-
14.8.1 CureTech Company Details
-
14.8.2 CureTech Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 CureTech Immune Checkpoint Inhibitors Product and Service
-
14.9 Immutep
-
14.9.1 Immutep Company Details
-
14.9.2 Immutep Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Immutep Immune Checkpoint Inhibitors Product and Service
-
14.10 AstraZeneca
-
14.10.1 AstraZeneca Company Details
-
14.10.2 AstraZeneca Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AstraZeneca Immune Checkpoint Inhibitors Product and Service
-
14.11 Innate Pharma
-
14.11.1 Innate Pharma Company Details
-
14.11.2 Innate Pharma Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Innate Pharma Immune Checkpoint Inhibitors Product and Service
-
14.12 Sorrento Therapeutics
-
14.12.1 Sorrento Therapeutics Company Details
-
14.12.2 Sorrento Therapeutics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Sorrento Therapeutics Immune Checkpoint Inhibitors Product and Service
-
14.13 MacroGenics
-
14.13.1 MacroGenics Company Details
-
14.13.2 MacroGenics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 MacroGenics Immune Checkpoint Inhibitors Product and Service
-
14.14 Incyte Corporation
-
14.14.1 Incyte Corporation Company Details
-
14.14.2 Incyte Corporation Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Incyte Corporation Immune Checkpoint Inhibitors Product and Service
-
14.15 GITR, Inc
-
14.15.1 GITR, Inc Company Details
-
14.15.2 GITR, Inc Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 GITR, Inc Immune Checkpoint Inhibitors Product and Service
-
14.16 Celldex Therapeutics
-
14.16.1 Celldex Therapeutics Company Details
-
14.16.2 Celldex Therapeutics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Celldex Therapeutics Immune Checkpoint Inhibitors Product and Service
-
14.17 GlaxoSmithKline
-
14.17.1 GlaxoSmithKline Company Details
-
14.17.2 GlaxoSmithKline Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 GlaxoSmithKline Immune Checkpoint Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Immune Checkpoint Inhibitors
-
Figure Immune Checkpoint Inhibitors Picture
-
Table Global Immune Checkpoint Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immune Checkpoint Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immune Checkpoint Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Immune Checkpoint Inhibitors Consumption by Country (2017-2022)
-
Figure United States Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Checkpoint Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PD-1/PD-L1 Consumption and Growth Rate (2017-2022)
-
Figure Global CTLA-4 Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global PD-1/PD-L1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CTLA-4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Immune Checkpoint Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Immune Checkpoint Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Immune Checkpoint Inhibitors Product and Service
-
Table ArGEN-X (Foundation Year, Company Profile and etc.)
-
Table ArGEN-X Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table ArGEN-X Immune Checkpoint Inhibitors Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Immune Checkpoint Inhibitors Product and Service
-
Table NewLink Genetics (Foundation Year, Company Profile and etc.)
-
Table NewLink Genetics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table NewLink Genetics Immune Checkpoint Inhibitors Product and Service
-
Table Roche / Genentech (Foundation Year, Company Profile and etc.)
-
Table Roche / Genentech Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche / Genentech Immune Checkpoint Inhibitors Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Immune Checkpoint Inhibitors Product and Service
-
Table Bristol Myer Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myer Squibb Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myer Squibb Immune Checkpoint Inhibitors Product and Service
-
Table CureTech (Foundation Year, Company Profile and etc.)
-
Table CureTech Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureTech Immune Checkpoint Inhibitors Product and Service
-
Table Immutep (Foundation Year, Company Profile and etc.)
-
Table Immutep Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immutep Immune Checkpoint Inhibitors Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Immune Checkpoint Inhibitors Product and Service
-
Table Innate Pharma (Foundation Year, Company Profile and etc.)
-
Table Innate Pharma Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innate Pharma Immune Checkpoint Inhibitors Product and Service
-
Table Sorrento Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Immune Checkpoint Inhibitors Product and Service
-
Table MacroGenics (Foundation Year, Company Profile and etc.)
-
Table MacroGenics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table MacroGenics Immune Checkpoint Inhibitors Product and Service
-
Table Incyte Corporation (Foundation Year, Company Profile and etc.)
-
Table Incyte Corporation Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Corporation Immune Checkpoint Inhibitors Product and Service
-
Table GITR, Inc (Foundation Year, Company Profile and etc.)
-
Table GITR, Inc Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table GITR, Inc Immune Checkpoint Inhibitors Product and Service
-
Table Celldex Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Celldex Therapeutics Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celldex Therapeutics Immune Checkpoint Inhibitors Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Immune Checkpoint Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Immune Checkpoint Inhibitors Product and Service
-
